Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites
Graphical abstract
Gespeichert in:
| Veröffentlicht in: | Journal of hepatology 2017-07, Vol.67 (1), p.40-46 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 46 |
|---|---|
| container_issue | 1 |
| container_start_page | 40 |
| container_title | Journal of hepatology |
| container_volume | 67 |
| creator | Sinha, Rohit Lockman, Khalida A Mallawaarachchi, Nethmee Robertson, Marcus Plevris, John N Hayes, Peter C |
| description | Graphical abstract |
| doi_str_mv | 10.1016/j.jhep.2017.02.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1869965969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827817300739</els_id><sourcerecordid>2080988961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-ba2f6004d76371451d4ea804ffceb75c356153604306229a99c6e85d7171d0393</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EotvCH-CALHHhkjD-iGNLCKlaQalUqQfgbLzOROuQTRY7Ceq_r6MtPfTQky_P-2r8zBDyjkHJgKlPXdnt8VhyYHUJvASoXpANUwAFKMlekk2GdKF5rc_IeUodAAgw8jU545ozwZTckN9bFxdsQj_2dE5IQ6IupdEHN2FD_4VpT8PhGMfM0DTHJSyup2GgRzcFHKZ0QvqwYKQ-xLgf01oxNLnGhwnTG_KqdX3Ctw_vBfn17evP7ffi5vbqent5U3ipxVTsHG_z5LKplaiZrFgj0WmQbetxV1deVIpVQoEUoDg3zhivUFdNzWrWgDDignw89eZh_86YJnsIyWPfuwHHOVmmlTGqMmpFPzxBu3GOQ57OctBgtDaKZYqfKB_HlCK29hjDwcU7y8Cu_m1nV_929W-B2-w_h94_VM-7AzaPkf_CM_D5BGB2sQSMNmvCwecVRPSTbcbwfP-XJ3HfhyF41__BO0yP_2A25YD9sV7AegCsFgB11nQPoLGqqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2080988961</pqid></control><display><type>article</type><title>Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sinha, Rohit ; Lockman, Khalida A ; Mallawaarachchi, Nethmee ; Robertson, Marcus ; Plevris, John N ; Hayes, Peter C</creator><creatorcontrib>Sinha, Rohit ; Lockman, Khalida A ; Mallawaarachchi, Nethmee ; Robertson, Marcus ; Plevris, John N ; Hayes, Peter C</creatorcontrib><description>Graphical abstract</description><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2017.02.005</identifier><identifier>PMID: 28213164</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Abdomen ; Adrenergic beta-Antagonists - therapeutic use ; Aged ; Ascites ; Ascites - drug therapy ; Ascites - mortality ; Beta blockers ; Bleeding ; Carbazoles - therapeutic use ; Carvedilol ; Cause of Death ; Cirrhosis ; Decompensated liver disease ; Drug therapy ; Female ; Gastroenterology and Hepatology ; Humans ; Liver cirrhosis ; Liver Cirrhosis - drug therapy ; Liver Cirrhosis - mortality ; Liver diseases ; Male ; Middle Aged ; Mortality ; Non-selective beta-blockers ; Patients ; Peritonitis ; Propanolamines - therapeutic use ; Prophylaxis ; Retrospective Studies ; Survival</subject><ispartof>Journal of hepatology, 2017-07, Vol.67 (1), p.40-46</ispartof><rights>European Association for the Study of the Liver</rights><rights>2017 European Association for the Study of the Liver</rights><rights>Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Jul 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-ba2f6004d76371451d4ea804ffceb75c356153604306229a99c6e85d7171d0393</citedby><cites>FETCH-LOGICAL-c483t-ba2f6004d76371451d4ea804ffceb75c356153604306229a99c6e85d7171d0393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168827817300739$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28213164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sinha, Rohit</creatorcontrib><creatorcontrib>Lockman, Khalida A</creatorcontrib><creatorcontrib>Mallawaarachchi, Nethmee</creatorcontrib><creatorcontrib>Robertson, Marcus</creatorcontrib><creatorcontrib>Plevris, John N</creatorcontrib><creatorcontrib>Hayes, Peter C</creatorcontrib><title>Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Graphical abstract</description><subject>Abdomen</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Aged</subject><subject>Ascites</subject><subject>Ascites - drug therapy</subject><subject>Ascites - mortality</subject><subject>Beta blockers</subject><subject>Bleeding</subject><subject>Carbazoles - therapeutic use</subject><subject>Carvedilol</subject><subject>Cause of Death</subject><subject>Cirrhosis</subject><subject>Decompensated liver disease</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis - drug therapy</subject><subject>Liver Cirrhosis - mortality</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Non-selective beta-blockers</subject><subject>Patients</subject><subject>Peritonitis</subject><subject>Propanolamines - therapeutic use</subject><subject>Prophylaxis</subject><subject>Retrospective Studies</subject><subject>Survival</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk1v1DAQhi0EotvCH-CALHHhkjD-iGNLCKlaQalUqQfgbLzOROuQTRY7Ceq_r6MtPfTQky_P-2r8zBDyjkHJgKlPXdnt8VhyYHUJvASoXpANUwAFKMlekk2GdKF5rc_IeUodAAgw8jU545ozwZTckN9bFxdsQj_2dE5IQ6IupdEHN2FD_4VpT8PhGMfM0DTHJSyup2GgRzcFHKZ0QvqwYKQ-xLgf01oxNLnGhwnTG_KqdX3Ctw_vBfn17evP7ffi5vbqent5U3ipxVTsHG_z5LKplaiZrFgj0WmQbetxV1deVIpVQoEUoDg3zhivUFdNzWrWgDDignw89eZh_86YJnsIyWPfuwHHOVmmlTGqMmpFPzxBu3GOQ57OctBgtDaKZYqfKB_HlCK29hjDwcU7y8Cu_m1nV_929W-B2-w_h94_VM-7AzaPkf_CM_D5BGB2sQSMNmvCwecVRPSTbcbwfP-XJ3HfhyF41__BO0yP_2A25YD9sV7AegCsFgB11nQPoLGqqg</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Sinha, Rohit</creator><creator>Lockman, Khalida A</creator><creator>Mallawaarachchi, Nethmee</creator><creator>Robertson, Marcus</creator><creator>Plevris, John N</creator><creator>Hayes, Peter C</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20170701</creationdate><title>Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites</title><author>Sinha, Rohit ; Lockman, Khalida A ; Mallawaarachchi, Nethmee ; Robertson, Marcus ; Plevris, John N ; Hayes, Peter C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-ba2f6004d76371451d4ea804ffceb75c356153604306229a99c6e85d7171d0393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abdomen</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Aged</topic><topic>Ascites</topic><topic>Ascites - drug therapy</topic><topic>Ascites - mortality</topic><topic>Beta blockers</topic><topic>Bleeding</topic><topic>Carbazoles - therapeutic use</topic><topic>Carvedilol</topic><topic>Cause of Death</topic><topic>Cirrhosis</topic><topic>Decompensated liver disease</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis - drug therapy</topic><topic>Liver Cirrhosis - mortality</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Non-selective beta-blockers</topic><topic>Patients</topic><topic>Peritonitis</topic><topic>Propanolamines - therapeutic use</topic><topic>Prophylaxis</topic><topic>Retrospective Studies</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sinha, Rohit</creatorcontrib><creatorcontrib>Lockman, Khalida A</creatorcontrib><creatorcontrib>Mallawaarachchi, Nethmee</creatorcontrib><creatorcontrib>Robertson, Marcus</creatorcontrib><creatorcontrib>Plevris, John N</creatorcontrib><creatorcontrib>Hayes, Peter C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sinha, Rohit</au><au>Lockman, Khalida A</au><au>Mallawaarachchi, Nethmee</au><au>Robertson, Marcus</au><au>Plevris, John N</au><au>Hayes, Peter C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>67</volume><issue>1</issue><spage>40</spage><epage>46</epage><pages>40-46</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><abstract>Graphical abstract</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28213164</pmid><doi>10.1016/j.jhep.2017.02.005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8278 |
| ispartof | Journal of hepatology, 2017-07, Vol.67 (1), p.40-46 |
| issn | 0168-8278 1600-0641 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1869965969 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Abdomen Adrenergic beta-Antagonists - therapeutic use Aged Ascites Ascites - drug therapy Ascites - mortality Beta blockers Bleeding Carbazoles - therapeutic use Carvedilol Cause of Death Cirrhosis Decompensated liver disease Drug therapy Female Gastroenterology and Hepatology Humans Liver cirrhosis Liver Cirrhosis - drug therapy Liver Cirrhosis - mortality Liver diseases Male Middle Aged Mortality Non-selective beta-blockers Patients Peritonitis Propanolamines - therapeutic use Prophylaxis Retrospective Studies Survival |
| title | Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A43%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carvedilol%20use%20is%20associated%20with%20improved%20survival%20in%20patients%20with%20liver%20cirrhosis%20and%20ascites&rft.jtitle=Journal%20of%20hepatology&rft.au=Sinha,%20Rohit&rft.date=2017-07-01&rft.volume=67&rft.issue=1&rft.spage=40&rft.epage=46&rft.pages=40-46&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2017.02.005&rft_dat=%3Cproquest_cross%3E2080988961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2080988961&rft_id=info:pmid/28213164&rft_els_id=S0168827817300739&rfr_iscdi=true |